Position in VTRS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,858
+$778 QoQ
Shares Held
243
+6.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#843
of 1,016 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Steigerwald, Gordon & Koch Inc. holds $2,428,147 across 8 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
33,674 | $2,419,813 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
167 | $4,109 | |
| 3 | VTRS |
Viatris Inc
This page
|
243 | $3,858 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
37 | $293 | |
| 5 | CGC |
Canopy Growth Corp
|
55 | $52 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
1 | $16 | |
| 7 | CRON |
Cronos Group Inc.
|
2 | $5 | |
| 8 | OGI |
Organigram Global Inc.
|
1 | $1 |
All Filings in VTRS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,858 | 243 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $3,080 | 228 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,838 | 228 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,277 | 230 | Shares | Sole | 2025-10-23 | |
| No filing history on record for this holder in this stock. | ||||||